DeepDOX1: A Dual-Drive Framework Integrating Deep Learning and First-Principles Physics for Drug-Protein Affinity Prediction
Liu, Z.; Sun, H.; Wang, Y.; Ren, Y.; Rao, L.; Huang, Z.; Cao, H.; Hu, X.; Zhu, X.; Li, M.; Wan, J.
Show abstract
In this work, we present DeepDOX1, a dual-drive drug-protein affinity (DPA) prediction tool features the tight integration of a concise AI architecture and a quantum mechanics based representation. The first-principle physics generated features incorporating the interactions between the drug and the protein pocket allows a relatively simple CNN model trained on a relatively small training set to exhibit exceptional generalization capabilities across extensive testing. Notably, DeepDOX1 outperforms popular AI models in the tests simulating real-world drug design scenario and a highly challenging test set featuring covalent ligands, halogenated ligands and metalloproteins. In addition, we designed a series of novel covalent inhibitors targeting the diabetes target hu-FBPase using DeepDOX1. Subsequent experimental validation including enzyme-level bioactivity assays and crystal structure determination confirmed the DeepDOX1s effectiveness in real-world drug design applications. It is conceivable that the combination of AI and first-principle QM might be one of the next breakthrough points of DPA prediction.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- AutoMolDesigner for Antibiotic Discovery: An AI-based Open-source Software for Automated Design of Small-molecule Antibiotics 98%
- A Simple Way to Incorporate Target Structural Information in Molecular Generative Models 98%
- DiffDec: Structure-Aware Scaffold Decoration with an End-to-End Diffusion Model 98%
Similar papers in this journal
- A Transferable Deep Learning Approach to Fast Screen Potent Antiviral Drugs against SARS-CoV-2 96%
- Revolutionizing GPCR-Ligand Predictions: DeepGPCR with experimental Validation for High-Precision Drug Discovery 96%
- Enhanced compound-protein binding affinity prediction by representing protein multimodal information via a coevolutionary strategy 95%
Similar papers in this journal
- Deep Generative Design with 3D Pharmacophoric Constraints 97%
- Structure-Aware Dual-Target Drug Design through Collaborative Learning of Pharmacophore Combination and Molecular Simulation 97%
- Transfer learning enables discovery of sub-micromolar antibacterials for ESKAPE pathogens from ultra-large chemical spaces 96%
Similar papers in this journal
- Using macromolecular electron densities to improve the enrichment of active compounds in virtual screening 95%
- EVOSYNTH: Enabling Multi-Target Drug Discovery through Latent Evolutionary Optimization and Synthesis-Aware Prioritization 95%
- A small molecule enhances arrestin-3 binding to the β2-adrenergic receptor 92%
Similar papers in this journal
- An artificial intelligence accelerated virtual screening platform for drug discovery 96%
- Integration of molecular coarse-grained model into geometric representation learning framework for protein-protein complex property prediction 94%
- First fully-automated AI/ML virtual screening cascade implemented at a drug discovery centre in Africa 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.